查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1837401

植入市場按產品類型、材料、最終用戶和分銷管道分類－2025-2032年全球預測

Bio-implant Market by Product Type, Material, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，植入市場規模將達到 1,110.6 億美元，複合年成長率為 4.91%。

主要市場統計數據
基準年 2024 756.5億美元
預計年份：2025年 794.5億美元
預測年份：2032年 1110.6億美元
複合年成長率 (%) 4.91%

這是一份策略性介紹，旨在闡明植入創新、監管演變、臨床需求和商業化重點在當今醫療保健生態系統中的地位。

本執行摘要概述了生物植入物領域複雜的環境，其中技術創新、監管演變和不斷變化的醫療模式相互交織，為植入相關人員創造了新的機會和營運挑戰。新型生物植入物植入和材料科學的進步正在重新定義植入的性能和耐久性，而對價值導向醫療的日益重視也推動了對臨床結果評估和成本透明度的新需求。同時，臨床醫生、工程師和支付方之間的跨領域合作正在加速將有前景的概念從實驗室轉化為臨床應用。

在此背景下，企業主管必須協調策略要務（例如加速創新週期、加強供應鏈和提升支付方參與度）與戰術性重點（例如植入選擇、外科醫生培訓和上市後監測）。因此，有效的策略需要在差異化技術投資與務實方法（例如監管合規、臨床醫生採納和分銷靈活性）之間取得平衡。透過這種方式，企業可以鞏固其在醫療保健生態系統中的地位，並在管控臨床、財務和營運風險的同時，為患者帶來可衡量的益處。

本文概述了技術、監管和護理模式的關鍵轉變，這些轉變正在重新定義植入開發商向患者和醫療保健提供者提供治療方法的方式。

由於技術、政策和臨床領域各方力量的匯聚，植入領域正經歷顯著的變化。生物材料的進步和設備小型化使得微創手術成為可能，並延長了設備的使用壽命，從而改變了醫保報銷的模式和臨床應用管道。同時，遠端監測和追蹤等數位醫療輔助技術的應用正在重塑術後護理，並為植入與患者數據生態系統的整合創造了機會。

法律規範也朝著更加重視真實世界證據和持續安全監測的方向發展，這提高了製造商證明其產品長期性能和以患者為中心的療效的標準。供應鏈重組和對區域韌性的關注正促使企業實現採購和製造地的多元化。總而言之，這些轉變要求企業採用敏捷的商業化模式，優先考慮臨床檢驗、資料互通性和夥伴關係，以滿足新的市場需求並維持長期成長。

分析2025年關稅政策對植入產業供應鏈、採購決策和生產韌性的實際和策略影響

2025年關稅政策對製造商、供應商和醫療保健機構產生了多方面的影響，遠不止成本大幅調整那麼簡單。關稅變化凸顯了在地化生產策略和供應商多元化對於降低跨境貿易中斷風險的重要性。對於依賴國際採購的企業而言，最直接的影響是加速推進近岸外包舉措，並評估替代材料供應商，以在確保產品品質的同時，盡可能減少利潤損失。

此外，醫院和門診手術中心的採購團隊已開始重新評估供應商合約和整體擁有成本 (TCO)，權衡不斷上漲的房地產購置成本與臨床績效指標。為此，製造商正優先考慮透明的成本模型、模組化產品設計以實現零件互換性，以及策略性庫存管理以維持供應的連續性。從長遠來看，這些調整正在影響合約動態，塑造供應商選擇標準，並促使企業重新專注於製造靈活性和監管協調，以維持全球市場進入。

將產品類型、材料選擇、臨床終端用戶和分銷管道與可操作的商業化和研發重點聯繫起來的詳細細分洞察

對市場區隔進行細緻入微的分析，可以揭示臨床需求與材料科學和分銷行為的交匯點，以及這些交會點應如何在產品組合策略中體現。依產品類型分類，我們提供心血管植入，包括人工心臟瓣膜、心律調節器、支架和血管移植物；人工植牙，包括骨內、骨膜下和經骨膜系統；神經植入，包括深層腦部刺激器、神經假體和脊髓刺激設備；以及整形外科植入，包括髖關節、膝關節、肩關節和脊柱植入物，其中髖關節植入物這些產品差異反映了不同的臨床工作流程、報銷管道和外科醫生培訓要求，因此需要量身定做證據產生和市場推廣策略。

從材料分類來看，主要類別包括陶瓷、複合材料、聚合物和鈦，其中聚合物可細分為可生物分解聚合物和超高分子量聚乙烯。材料的選擇必須與臨床終點和生產能力相匹配，因為它直接影響器械的使用壽命、生物相容性、滅菌方案和監管文件。從終端使用者的角度來看，門診手術中心、診所、醫院和研究機構的需求分佈表明，它們的採購週期、競標流程和臨床實施時間表各不相同。

最後，通路動態取決於線上和線下分銷模式的共存。雖然線下管道在臨床試驗和需要無菌物流的高度複雜器械領域仍然佔據主導地位，但線上管道正在逐步擴展到輔助組件、耗材和資訊傳播領域。因此，策略性細分分析必須整合產品複雜性、材料限制、終端用戶購買行為和通路適用性等因素，以便確定投資和營運重點的優先順序。

全球主要市場的關鍵區域動態和差異化策略，旨在協調監管環境、臨床實踐和採購行為。

區域動態透過不同的管理體制、支付方格局和臨床基礎設施塑造競爭優勢，因此，基於地理因素的策略對於有效進入和拓展市場至關重要。在美洲，強大的公私支付方參與以及先進的外科手術網路正在推動高價值植入的快速普及，同時也要求提供嚴格的成本效益和長期療效證據。同時，歐洲、中東和非洲是一個異質性環境，監管協調工作與各國報銷政策的差異並存，因此需要靈活的市場進入計劃和本地合作夥伴關係，以確保處方箋獲得批准和臨床醫生的認可。

亞太地區擁有龐大的規模化發展機會，這得益於其龐大的手術量、不斷成長的醫療保健投資以及良好的製造業生態系統。然而，成功與否取決於產品能否適應當地的臨床實踐和價格敏感度。由於各全部區域的臨床訓練標準、採購週期和醫院基礎設施存在差異，因此需要針對特定地區的臨床證據包裝、定價策略和供應鏈配置進行調整。區域優先排序和客製化的合作模式正在加速產品應用，同時降低執行風險。

競爭行為分析表明，產品平台思維、臨床夥伴關係和供應鏈韌性如何創造可衡量的差異化和商業性優勢。

植入領域的主要企業正利用技術差異化、臨床夥伴關係和營運規範結合的方式，確立自身的競爭優勢。成功的企業正投資開發模組化平台，以加快不同型號產品的上市速度，並利用與領先臨床中心的夥伴關係，以取得可靠的真實世界證據。這些企業也優先發展材料科學創新，將先進聚合物、陶瓷和鈦合金與表面處理技術結合，以提高生物相容性、降低重新置換率，並增強臨床和醫療保險方面的說服力。

從營運角度來看，一流企業正透過多通路採購、區域製造地和數位化追溯解決方案建構具有韌性的供應鏈，以滿足監管要求並控制關稅風險。此外，將數位健康功能（例如遠端監測和數據分析）整合到植入式醫療設備中的企業，能夠提供差異化的提案，從而支援更完善的療效評估和上市後監測。因此，兼具臨床可靠性、材料和設計創新以及靈活商業模式的企業，其競爭優勢日益凸顯。

為領導階層提供切實可行的建議，這些建議結合了產品平台策略、證據產生、供應鏈韌性以及能夠帶來可衡量影響的有針對性的市場推廣策略。

領導者應採取平衡的策略，透過有針對性的投資和切實可行的營運變革，在加速創新的同時降低商業化風險。首先，應優先發展模組化產品平台和可製造性設計，以實現零件替換和加快法規核准流程。同時，應投資於嚴謹的真實世界證據項目和結構化的上市後測試，以驗證長期療效並支持與支付方的談判。此類數據舉措應與臨床合作夥伴協調，以確保其有效性和應用價值。

第二，透過供應商多元化、評估近岸外包機會以及實施數位化追溯系統來增強供應鏈韌性，從而提高庫存可見度和合規性。第三，根據區域和終端使用者的實際情況，調整定價、臨床證據和培訓計劃，以滿足醫院、門診手術中心、診所和研究機構的特定需求，從而製定符合當地實際情況的打入市場策略進入策略。最後，採用遠端監測和患者互動工具等數位化工具，以增強植入價值提案並促進以結果主導的合約簽訂。這些措施有助於機構增強臨床信心、降低營運風險並確保永續的收入管道。

對嚴謹的多方法研究途徑、主要相關人員訪談以及用於獲取可靠且可操作見解的分析技術進行了清晰的闡述。

本報告採用多方法研究途徑，結合一手質性訪談、二手文獻回顧和比較個案分析，以確保分析的嚴謹性和實用性。一手研究包括對臨床醫生、採購負責人、相關人員和設備工程師進行結構化訪談，以了解不同相關人員對臨床效用、推廣障礙和採購標準的觀點。這些見解與二手資訊（包括同行評審的臨床研究、監管文件和公開的政策文件）進行三角驗證，以檢驗趨勢並支持技術論點。

分析方法包括情境對比分析，以檢驗不同監管和貿易條件下的策略應對措施；以及跨區域基準化分析，以識別市場進入和供應鏈設計的最佳實踐。品管包括來源檢驗、專家同行評審和敏感性檢查，以確保研究結果的可靠性和可操作性。整體而言，重點在於對產品開發、商業策略和營運執行的實際意義。

這份簡明扼要的結論總結強化了將技術進步轉化為臨床應用和永續商業性成功的策略重點。

摘要：植入產業正處於技術快速發展和日益複雜的商業營運的交匯點，需要製定兼顧技術創新與務實開展業務的整合策略。將平台設計、材料專業知識和可靠的真實世界證據與穩健的供應鏈和區域性市場推廣計劃相結合的利益相關者，最能將科學進步轉化為永續的商業性成功。此外，不斷變化的關稅和法規環境凸顯了靈活的生產和籌資策略的重要性，相關人員策略既要保護淨利率，又要確保臨床品質。

展望未來，積極投資臨床醫師夥伴關係、上市後數據系統和數位化支援工具的機構，不僅能改善病患療效，還能加強與支付方的溝通，並為自身的長期發展奠定基礎。要實現這一目標，需要有條不紊地進行優先排序、跨部門協調，並願意根據新的證據和地緣政治現實調整經營模式。這樣做將使企業能夠在應對快速變化的全球醫療保健體系中固有風險的同時，抓住新的機會。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 生物可分解神經介面植入的進展將增強腦機通訊
  • 將無線電力傳輸技術整合到長期心臟設備中
  • 人工智慧驅動的預測性維護系統的出現，旨在最佳化整形外科植入的性能
  • 開發嵌入生長因子的3D列印患者特異性支架以促進癒合
  • 植入式生物電子醫療設備安全測試全球監管標準的趨同

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型植入市場

  • 心血管植入
    • 人工心臟瓣膜
    • 心律調節器
    • 支架
    • 血管移植
  • 人工植牙
    • 骨內植入
    • 骨膜下植入
    • 骨穿透性植入
  • 神經植入
    • 深層腦部刺激器
    • 神經假體
    • 脊髓刺激設備
  • 眼科植入
    • 角膜植入
    • 人工水晶體
    • 視網膜植入
  • 整形外科植入
    • 髖植入
      • 髖重組
      • 全髖置換術
    • 膝關節植入
      • 部分膝關節關節重建
      • 全膝關節關節重建
    • 肩關節關節移植
    • 脊椎移植

第9章植入市場（依材料分類）

  • 陶瓷製品
  • 複合材料
  • 聚合物
    • 可生物分解聚合物
    • UHMWPE
  • 鈦

第10章 依最終用戶分類的植入市場

  • 門診手術中心
  • 診所
  • 醫院
  • 研究所

第11章植入市場（依分銷管道分類）

  • 離線
  • 線上

第12章植入市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章植入市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國植入市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • BioHorizons
    • Dentsply Sirona Inc
    • HIOSSEN
    • Institut Straumann AG
    • MEGA'GEN IMPLANT CO.,LTD.
    • Nobel Biocare Services AG
    • NuVasive, Inc.
    • OSSTEM IMPLANT CO., LTD.
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc
Product Code: MRR-0355054AC501

The Bio-implant Market is projected to grow by USD 111.06 billion at a CAGR of 4.91% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 75.65 billion
Estimated Year [2025] USD 79.45 billion
Forecast Year [2032] USD 111.06 billion
CAGR (%) 4.91%

A strategic introduction that positions bio-implant innovation, regulatory evolution, clinical demand, and commercialization priorities within today's healthcare ecosystem

This executive summary frames a complex environment where technological innovation, regulatory evolution, and shifting care models converge to create new opportunities and operational challenges for bio-implant stakeholders. Emerging device architectures and material science advances are redefining device performance and durability, while the growing emphasis on value-based care places new demands on clinical outcome measurement and cost transparency. Meanwhile, cross-discipline collaboration between clinicians, engineers, and payers is increasing the rate at which promising concepts move from bench to bedside.

Against this backdrop, executives must reconcile strategic imperatives-such as faster innovation cycles, supply chain resilience, and payer engagement-with tactical priorities like implant selection, surgical training, and post-market surveillance. Effective strategies will therefore balance investment in differentiated technologies with practical approaches to regulatory compliance, clinician adoption, and distribution agility. In doing so, organizations can strengthen their position within healthcare ecosystems and deliver measurable patient benefits while managing clinical, financial, and operational risk.

An overview of the major technological, regulatory, and care model shifts that are redefining how bio-implant developers bring therapies to patients and providers

The landscape for bio-implants is undergoing transformative shifts driven by converging forces across technology, policy, and clinical practice. Advances in biomaterials and device miniaturization are enabling less invasive procedures and extending device longevity, which in turn alters reimbursement conversations and clinical pathways. Concurrently, the adoption of digital health adjuncts such as remote monitoring and tele-follow up is reshaping post-operative care, creating opportunities for implants that integrate with patient data ecosystems.

Regulatory frameworks are also moving toward increased emphasis on real-world evidence and continuous safety monitoring, which raises the bar for manufacturers to demonstrate longitudinal performance and patient-centered outcomes. Supply chain reconfiguration and a focus on regional resilience are prompting firms to diversify sourcing and manufacturing footprints. Taken together, these shifts require companies to adopt nimble commercialization models that prioritize clinical validation, data interoperability, and collaborative partnerships to capture emerging demand and sustain long-term growth.

An analysis of the practical and strategic consequences of the 2025 tariff landscape on supply chains, procurement decisions, and manufacturing resilience across the bio-implant sector

The tariff actions introduced in 2025 have created a layered set of implications for manufacturers, suppliers, and healthcare providers that extend beyond headline cost adjustments. Tariff changes have increased the importance of localized production strategies and supplier diversification to mitigate exposure to cross-border trade disruptions. For organizations reliant on international sourcing, the immediate effect has been an acceleration of nearshoring initiatives and an evaluation of alternate material suppliers to preserve device quality while limiting margin erosion.

Furthermore, procurement teams within hospitals and ambulatory surgical centers have begun to re-assess vendor contracts and total cost of ownership, weighing increased landed costs against clinical performance metrics. In response, manufacturers have prioritized transparent cost models, modular product designs that allow component substitution, and strategic inventory management to maintain continuity of supply. Over time, these adaptations are influencing contractual dynamics, shaping supplier selection criteria, and prompting renewed emphasis on manufacturing flexibility and regulatory harmonization to sustain global market access.

In-depth segmentation insights that connect product categories, material choices, clinical end users, and distribution channels to practical commercialization and R&D priorities

A nuanced view of segmentation reveals where clinical demand intersects with material science and distribution behaviors, and how those intersections should inform portfolio strategy. Based on product type, the market spans cardiovascular implants including artificial heart valves, pacemakers, stents, and vascular grafts; dental implants such as endosseous, subperiosteal, and transosteal systems; neurological implants including deep brain stimulators, neuroprosthetics, and spinal cord stimulators; ophthalmic implants encompassing corneal substitutes, intraocular lenses, and retinal devices; and orthopedic implants with hip, knee, shoulder, and spinal options, where hip devices further differentiate into hip resurfacing and total hip replacement and knee solutions distinguish partial knee replacement from total knee replacement. These product distinctions reflect divergent clinical workflows, reimbursement pathways, and surgeon training requirements, and they necessitate tailored evidence generation and go-to-market approaches.

Turning to material segmentation, key categories include ceramic, composite, polymer, and titanium, with polymers subdivided into biodegradable polymers and ultra-high molecular weight polyethylene variants. Material choice has direct implications for device longevity, biocompatibility, sterilization protocols, and regulatory dossiers, and therefore must align with clinical endpoints and manufacturing capabilities. From an end-user perspective, the distribution of demand across ambulatory surgical centers, clinics, hospitals, and research institutes indicates differing purchasing cycles, tender processes, and clinical adoption timelines; each end-user type presents unique requirements for packaging, training, and post-sales support.

Finally, channel dynamics hinge on the coexistence of offline and online distribution models. Offline channels remain dominant for high-complexity devices requiring clinical demonstrations and sterile logistics, while online channels are gradually expanding for ancillary components, consumables, and information dissemination. Strategic segmentation analysis should therefore integrate product complexity, material constraints, end-user procurement behavior, and channel suitability to prioritize investments and operational focus.

Key regional dynamics and differentiated strategies that align regulatory landscapes, clinical practices, and procurement behaviors across major global markets

Regional dynamics are shaping competitive advantage through differing regulatory regimes, payer landscapes, and clinical infrastructures, and a geographically informed strategy is essential for effective market entry and expansion. In the Americas, strong private and public payer engagement combined with advanced surgical networks fosters rapid adoption of high-value implants, but it also demands rigorous evidence of cost effectiveness and longitudinal performance. Meanwhile, Europe, Middle East & Africa presents a heterogeneous environment in which regulatory harmonization efforts coexist with country-level reimbursement idiosyncrasies, requiring nimble market access planning and local partnerships to secure formulary placement and clinician endorsement.

In Asia-Pacific, a combination of high surgical volumes, growing healthcare investment, and favorable manufacturing ecosystems creates significant opportunities for scale, yet success depends on adapting products to local clinical practices and price sensitivity. Across these regions, differences in clinical training standards, procurement cycles, and hospital infrastructure necessitate region-specific clinical evidence packages, pricing strategies, and supply chain configurations. Therefore, thoughtful regional prioritization and tailored engagement models will accelerate adoption while reducing execution risk.

Insights into competitive behaviors where product platform thinking, clinical partnership, and supply chain resilience create measurable differentiation and commercial advantage

Leading companies in the bio-implant arena are demonstrating a mix of technology differentiation, clinical partnership, and operational discipline that defines competitive positioning. Successful organizations are investing in modular platform development to reduce time to market for variant devices and leveraging partnerships with leading clinical centers to generate robust real-world evidence. These firms also prioritize materials science innovation-combining advanced polymers, ceramics, and titanium alloys with surface treatments-to improve biocompatibility and reduce revision rates, thereby strengthening clinical and payer narratives.

Operationally, top performers are building resilient supply chains through multi-sourcing, regional manufacturing footprints, and digital traceability solutions to meet regulatory expectations and manage tariff exposure. In addition, companies that have integrated digital health capabilities around implantable devices-such as remote monitoring and data analytics-are creating differentiated propositions that support outcomes-based contracting and enhanced post-market surveillance. As a result, competitive advantage increasingly accrues to firms that combine clinical credibility, material and design innovation, and adaptable commercial models.

Actionable recommendations for leadership that combine product platform strategy, evidence generation, supply chain resilience, and targeted market access initiatives for measurable impact

Leaders should pursue a balanced agenda that accelerates innovation while de-risking commercialization through targeted investments and pragmatic operational changes. First, prioritize modular product platforms and design for manufacturability to enable component substitution and faster regulatory pathways. In parallel, invest in rigorous real-world evidence programs and structured post-market studies that demonstrate long-term outcomes and support payer negotiations. These data initiatives should be coordinated with clinical partners to ensure relevance and adoption.

Second, strengthen supply chain resilience by diversifying suppliers, evaluating near-shoring opportunities, and implementing digital traceability systems to improve inventory visibility and compliance. Third, tailor market access strategies to regional and end-user realities by aligning pricing, clinical evidence, and training programs with the specific needs of hospitals, ambulatory surgical centers, clinics, and research institutes. Finally, embrace digital adjuncts such as remote monitoring and patient engagement tools to enhance the value proposition of implants and facilitate outcome-driven contracting. Together, these actions will help organizations capture clinical trust, reduce operational risk, and unlock sustainable revenue pathways.

A clear description of the rigorous multi-method research approach, primary stakeholder interviews, and analytical techniques used to produce reliable and actionable insights

This report synthesizes a multi-method research approach combining primary qualitative interviews, secondary literature synthesis, and comparative case analysis to ensure analytical rigor and practical relevance. Primary research included structured interviews with clinicians, procurement leaders, regulatory specialists, and device engineers to capture diverse stakeholder perspectives on clinical utility, adoption barriers, and purchasing criteria. These insights were triangulated with secondary sources such as peer-reviewed clinical studies, regulatory filings, and publicly available policy documents to validate trends and corroborate technical claims.

Analytical methods employed comparative scenario analysis to test strategic responses under varying regulatory and trade conditions, and cross-regional benchmarking to identify best practices in market access and supply chain design. Quality control measures included source verification, expert peer review, and sensitivity checks to ensure findings are robust and actionable. Throughout, emphasis was placed on practical implications for product development, commercial strategy, and operational execution.

A concise concluding synthesis that reinforces strategic priorities for converting technological advances into clinical adoption and sustainable commercial success

In summary, the bio-implant sector sits at the intersection of rapid technological progress and heightened operational complexity, demanding integrated strategies that marry innovation with pragmatic execution. Stakeholders who align platform design, materials expertise, and robust real-world evidence with resilient supply chains and regionally tailored market access plans are best positioned to convert scientific advances into durable commercial success. Moreover, the evolving tariff and regulatory environment underscores the need for flexible manufacturing and sourcing strategies that protect margins without sacrificing clinical quality.

Looking ahead, organizations that proactively invest in clinician partnerships, post-market data systems, and digital adjuncts will not only enhance patient outcomes but also strengthen payer conversations and long-term viability. The path forward requires disciplined prioritization, cross-functional coordination, and a willingness to adapt business models to new evidence and geopolitical realities. By doing so, companies can capture emerging opportunities while managing the risks inherent in a rapidly changing global healthcare landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advancements in biodegradable neural interface implants enhancing brain-computer communication
  • 5.2. Integration of wireless power transfer technology in cardiac bio-implant devices for long-term use
  • 5.3. Emergence of AI-driven predictive maintenance systems for optimizing performance of orthopedic implants
  • 5.4. Development of 3D-printed patient-specific bio-implant scaffolds with embedded growth factors to accelerate healing
  • 5.5. Regulatory convergence on global standards for safety testing of implantable bioelectronic medical devices

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bio-implant Market, by Product Type

  • 8.1. Cardiovascular Implants
    • 8.1.1. Artificial Heart Valves
    • 8.1.2. Pacemakers
    • 8.1.3. Stents
    • 8.1.4. Vascular Grafts
  • 8.2. Dental Implants
    • 8.2.1. Endosseous Implants
    • 8.2.2. Subperiosteal Implants
    • 8.2.3. Transosteal Implants
  • 8.3. Neurological Implants
    • 8.3.1. Deep Brain Stimulators
    • 8.3.2. Neuroprosthetics
    • 8.3.3. Spinal Cord Stimulators
  • 8.4. Ophthalmic Implants
    • 8.4.1. Corneal Implants
    • 8.4.2. Intraocular Lenses
    • 8.4.3. Retinal Implants
  • 8.5. Orthopedic Implants
    • 8.5.1. Hip Implants
      • 8.5.1.1. Hip Resurfacing
      • 8.5.1.2. Total Hip Replacement
    • 8.5.2. Knee Implants
      • 8.5.2.1. Partial Knee Replacement
      • 8.5.2.2. Total Knee Replacement
    • 8.5.3. Shoulder Implants
    • 8.5.4. Spinal Implants

9. Bio-implant Market, by Material

  • 9.1. Ceramic
  • 9.2. Composite
  • 9.3. Polymer
    • 9.3.1. Biodegradable Polymers
    • 9.3.2. Uhmwpe
  • 9.4. Titanium

10. Bio-implant Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals
  • 10.4. Research Institutes

11. Bio-implant Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Bio-implant Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bio-implant Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bio-implant Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. BioHorizons
    • 15.3.2. Dentsply Sirona Inc
    • 15.3.3. HIOSSEN
    • 15.3.4. Institut Straumann AG
    • 15.3.5. MEGA'GEN IMPLANT CO.,LTD.
    • 15.3.6. Nobel Biocare Services AG
    • 15.3.7. NuVasive, Inc.
    • 15.3.8. OSSTEM IMPLANT CO., LTD.
    • 15.3.9. Stryker Corporation
    • 15.3.10. Zimmer Biomet Holdings, Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BIO-IMPLANT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BIO-IMPLANT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BIO-IMPLANT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIO-IMPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIO-IMPLANT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIO-IMPLANT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS BIO-IMPLANT MARKET SIZE, BY POLYMER, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS BIO-IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2025-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 336. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 342. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2024 (US